Search Results 161-170 of 10482 for Terminal
CHF is associated with increased concentrations of circulating norepinephrine (NE), down-regulation of adrenergic nerve terminals, and abnormal NE reuptake.
Terminal illness (other than HF) with expected survival of less than 1 year. Enrollment or planned enrollment in another therapeutic clinical trial in next ...
Though I had had my thyroid irradiated in 2017, an autoimmune reaction within my body led to a further diagnosis of severe thyroid eye disease. By May 2021, my ...
Terminal illness (other than HF) with expected survival of less than 1 year; Regularly (> 1x per week) swims or does water aerobics; Enrollment or planned ...
... terminal-pro-brain natriuretic peptide (NT-proBNP) within 90 days of randomization: For patients in normal sinus rhythm: N-terminal-probrain natriuretic ...
... terminal half-life of the previous experimental medication. Patients with current clinically significant medical comorbidities that might pose a potential ...
Learn about the symptoms, causes and prevention of this cancer that starts in the rectum. Treatments include surgery, radiation therapy and chemotherapy.
Learn about this nerve condition that can jolt areas on the face with electric-shock-like pain.
... terminal deoxynucleotidyl transferase (TdT), CD34 or CD99 will be assessed for expression; cases with uncertain expression will receive additional review ...
Life expectancy of less than 24 months due to co-morbid terminal conditions. Pre-morbid mRS > 3. ICH score > 3 upon presentation. Contraindications to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!